Rhumbline Advisers Kazia Therapeutics LTD Put Options Transaction History
Rhumbline Advisers
- $103 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding KZIA
# of Institutions
12Shares Held
323KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY198KShares$41,5480.0% of portfolio
-
Hsbc Holdings PLC London, X064KShares$13,4300.0% of portfolio
-
Xtx Topco LTD London, X018.5KShares$3,8820.0% of portfolio
-
Two Sigma Securities, LLC New York, NY18.4KShares$3,8690.0% of portfolio
-
Ground Swell Capital, LLC Folly Beach, SC11.2KShares$2,3410.0% of portfolio
About KAZIA THERAPEUTICS LTD
- Ticker KZIA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,111,300
- Market Cap $3.17M
- Description
- Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...